![Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021 | MMWR Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7102e1_PfizerMIS-C_IMAGE_07Jan22_SOCIAL_1200x675.jpg?_=63592)
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021 | MMWR
![Risk factors for multisystem inflammatory syndrome in children – A population-based cohort study of over 2 million children - The Lancet Regional Health – Europe Risk factors for multisystem inflammatory syndrome in children – A population-based cohort study of over 2 million children - The Lancet Regional Health – Europe](https://www.thelancet.com/cms/attachment/ea43f8b1-4d53-4ff9-82a3-52539da06281/gr1_lrg.jpg)
Risk factors for multisystem inflammatory syndrome in children – A population-based cohort study of over 2 million children - The Lancet Regional Health – Europe
![Master of Information Science: Programs: Department of Information & Library Science: Indiana University Bloomington Master of Information Science: Programs: Department of Information & Library Science: Indiana University Bloomington](https://ils.indiana.edu/images/programs/mis-venn-diagram.png)